Sorafenib Is Beneficial for Patients With Advanced RCC and CVD in a Real-World Setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Real-World Use of Sorafenib for Advanced Renal Cell Carcinoma Patients With Cardiovascular Disease: Nationwide Survey in Japan
Expert Rev Anticancer Ther 2020 May 22;[EPub Ahead of Print], T Inamoto, H Azuma, K Tatsugami, M Oya, M Adachi, Y Okayama, T Sunaya, H AkazaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.